Evaluation of a New High-Throughput Next-Generation Sequencing Method Based on a Custom AmpliSeq™ Library and Ion Torrent PGM™ Sequencing for the Rapid Detection of Genetic Variations in Long QT Syndrome

Molecular Diagnosis and Therapy

Volumn 18, Issue 5, 2014, Pages 533-539

  Millat, Gilles ^a,b   Chanavat, Valérie ^a   Rousson, Robert ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMICS; EVALUATION STUDY; GENETIC VARIABILITY; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; LONG QT SYNDROME; MOLECULAR DIAGNOSIS; MUTATION; NUCLEOTIDE SEQUENCE; PROCEDURES;

DNA MUTATIONAL ANALYSIS; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LONG QT SYNDROME; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION;

EID: 84897121708     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/s40291-014-0099-y     Document Type: Article

References (15)

1. Abriel H, Zaklyazminskaya EV. Cardiac channelopathies: genetic and molecular mechanisms. Gene. 2013;517:1–11.
2. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120:1761–7.
3. Ruan Y, Liu N, Napolitano C, Priori SG. Therapeutic strategies for long-QT syndrome: does the molecular substrate matter? Circ Arrhythm Electrophysiol. 2008;1:290–7.
4. Millat G, Chanavat V, Créhalet H, Rousson R. Development of a high resolution melting method for the detection of genetic variations in Long QT Syndrome. Clin Chim Acta. 2011;412:203–7.
5. Millat G, Chevalier P, Restier-Miron L, et al. Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin Genet. 2006;70:214–27.
6. Millat G, Chanavat V, Rodriguez-Lafrasse C, Rousson R. Rapid, sensitive and inexpensive detection of SCN5A genetic variations by high resolution melting analysis. Clin Biochem. 2009;42:491–9.
7. Sikkema-Raddatz B, Johansson LF, de Boer EN, et al. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Hum Mutat. 2013;34:1035–42.
8. Ware JS, John S, Roberts AM, et al. Next generation diagnostics in inherited arrhythmia syndromes: a comparison of two approaches. J Cardiovasc Transl Res. 2013;6:94–103.
9. Lieve KV, Williams L, Daly A, et al. Results of genetic testing in 855 consecutive unrelated patients referred for long QT syndrome in a clinical laboratory. Genet Test Mol Biomarkers. 2013;17:553–61.
10. Tarabeux J, Zeitouni B, Moncoutier V, et al. Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model. Eur J Hum Genet. 2014;22:535–41.
11. AbouTayoun AN, Tunkey CD, Pugh TJ, et al. A comprehensive assay for CFTR mutational analysis using next-generation sequencing. Clin Chem. 2013;59:1481–8.
12. Elliott AM, Radecki J, Moghis B, Li X, Kammesheidt A. Rapid detection of the ACMG/ACOG-recommended 23 CFTR disease-causing mutations using ion torrent semiconductor sequencing. J Biomol Tech. 2012;23:24–30.
13. Yeo ZX, Chan M, Yap YS, Ang P, Rozen S, Lee AS. Improving indel detection specificity of the Ion Torrent PGM benchtop sequencer. PLoS One. 2012;7:e45798.
14. Chin EL, da Silva C, Hegde M. Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations. BMC Genet. 2013;14:6.
15. Barc J, Briec F, Schmitt S, et al. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance. J Am Coll Cardiol. 2011;57:40–7.